Opko Health (Israel) Management Performance Evaluation

OPK -- Israel Stock  

ILS 1,310  16.00  1.24%

Analysis of Opko Health manpower and management performance can provide insight into Opko Health stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Opko Health future performance. Additionally take a look at Your Equity Center.

Opko Health Management Effectiveness

The company has return on total asset (ROA) of (6.17) % which means that it has lost $6.17 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (15.66) % meaning that it generated substantial loss on money invested by shareholders.

Opko Health Profit Margins

The company has Profit Margin (PM) of (29.87) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (25.46) % which suggests for every $100 dollars of sales it generated a net operating loss of -0.25.

Opko Health Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of seventeen. Opko Health Price Series Summation is a cross summation of Opko Health price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.

Opko Health Stakeholders

Philip Frost Chairman of the Board, CEO
Phillip Frost Chairman of the Board, CEO
Jane Hsiao Vice Chairman of the Board, Chief Technical Officer
Steven Rubin Executive Vice President - Administration, Director
Akhtar Ashfaq Senior Vice President - Clinical Research and Development of OPKO Health's Renal Division
Adam Logal CFO, Chief Accounting Officer, Sr. VP and Treasurer
Robert Fishel Independent Director
Robert Baron Independent Director
Alice Yu Independent Director
Richard Lerner Independent Director
Dmitry Kolosov Independent Director
Richard Pfenniger Independent Director
Thomas Beier Director
John Paganelli Independent Director
Richard Krasno Independent Director
Anne Fields IR Contact Officer
Thomas Nusbickel Chief Commercial Officer of the Company's Renal Division
Miriam Miller IR Contact Officer

Opko Health Leadership

Opko Health Top Executives

  Philip Frost  Chairman
Chairman of the Board, CEO
  Phillip Frost  Chairman
Chairman of the Board, CEO

Opko Health Tenure Analysis

Opko Health Employment Tenure

Opko Health employes about 6030 people. The company is managed by 18 executives with total tenure of roughly 123 years, averanging almost 6.0 years of service per executive having 335.0 employee per reported executive.

Opko HealthManpower Efficiency

Return on Opko Health Manpower

Revenue Per Employee170.8 K
Revenue Per Executive57.2 M
Net Loss Per Employee50.9 K
Net Loss Per Executive17 M
Additionally take a look at Your Equity Center. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.
Search macroaxis.com